- Home
- CPRX vs LBTYK Comparison
CPRX vs LBTYK Comparison
Compare CPRX & LBTYK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CPRX | LBTYK |
|---|---|---|
| Founded | 2002 | 2004 |
| Country | United States | Bermuda |
| Employees | N/A | 6636 |
| Industry | Biotechnology: Pharmaceutical Preparations | Cable & Other Pay Television Services |
| Sector | Health Care | Telecommunications |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.4B | 4.0B |
| IPO Year | 2006 | N/A |
Fundamental Metrics
Financial Performance| Metric | CPRX | LBTYK |
|---|---|---|
| Price | $31.28 | $12.17 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $35.00 | N/A |
| AVG Volume (30 Days) | ★ 2.9M | 1.1M |
| Earning Date | 05-11-2026 | 02-18-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 28.24 | N/A |
| EPS | ★ 0.50 | N/A |
| Revenue | ★ $119,072,803.00 | N/A |
| Revenue This Year | $9.20 | $15.41 |
| Revenue Next Year | $10.51 | $3.03 |
| P/E Ratio | $62.58 | ★ N/A |
| Revenue Growth | ★ 16.39 | N/A |
| 52 Week Low | $19.05 | $9.67 |
| 52 Week High | $32.56 | $13.12 |
Technical Indicators
Market Signals| Indicator | CPRX | LBTYK |
|---|---|---|
| Relative Strength Index (RSI) | 72.86 | 59.94 |
| Support Level | $31.00 | $11.39 |
| Resistance Level | $31.33 | $12.19 |
| Average True Range (ATR) | 0.08 | 0.36 |
| MACD | -0.19 | 0.06 |
| Stochastic Oscillator | 81.94 | 99.50 |
Price Performance
Historical ComparisonAbout CPRX Catalyst Pharmaceuticals Inc.
Catalyst Pharmaceuticals Inc is a commercial-stage, patient-centric biopharmaceutical company focused on in-licensing, developing, and commercializing novel high-quality medicines for patients living with rare and difficult to treat diseases. The Company sells three commercial stage drug products, FIRDAPSE (amifampridine), AGAMREE (vamorolone), and FYCOMPA (perampanel). The Company is currently seeking to further expand its product portfolio, with a focus on acquiring the rights to immediately and near-term accretive assets to treat rare (orphan) diseases across therapeutic areas, including clinical-stage opportunities with established proof of concept.
About LBTYK Liberty Global Ltd. Class C
Liberty Global is a holding company with interests in European telecom companies in the UK, the Netherlands, Belgium, Ireland, and Slovakia. Liberty owns the main cable network in each of these geographies and has pursued a strategy since 2016 to merge or partner with mobile network operators to be able to offer converged services. Liberty also owns minority stakes in other media, entertainment, and cloud companies.